Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

EXPRESS: Single-tracer [<sup>18</sup>F]FDG PET quantification of blood-brain barrier permeability and cerebral blood flow: Validation using dual-tracer PET.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Age-Related Low Frequency Amplitude Differences in Resting-State Blood Oxygenation Level-Dependent Signal in the Cerebellum.

Human brain mapping·2026
Same author

Sharing a whole-/total-body [<sup>18</sup>F]FDG-PET/CT dataset with CT-derived segmentations: an ENHANCE.PET initiative.

Scientific data·2026
Same author

Dose-aware diffusion model for 3D PET image denoising: Multi-institutional validation with reader study and real low-dose data.

Medical image analysis·2026
Same author

Monte Carlo-based scatter correction for the plastic-based modular PET scanner J-PET.

Physics in medicine and biology·2026
Same author

Incorporating Tissue Composition Information in Total-Body PET Metabolic Quantification of Bone Marrow through Dual-Energy CT.

ArXiv·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Emily N Holy1, Guobao Wang1, Benjamin A Spencer1

  • 1University of California Davis, Davis, CA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

阿尔茨海默氏病 (AD) 粉样β (Aβ) 可以通过全身PET成像在肝脏中检测到. 在AD患者中肝脏Aβ信号增加表明肝脏是疾病进展的潜在生物标志物.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 医疗成像医学成像
  • 生物化学 生物化学

背景情况:

  • 阿尔茨海默病 (AD) 的特征是大脑中的粉样ββ (Aβ) 斑块.
  • 在肝脏等外围器官中,Aβ也存在并降解.
  • 目前对阿尔茨海默病的PET成像仅限于大脑,忽视了全身Aβ分布.

研究的目的:

  • 利用全身PET成像来描述肝脏的Aβ信号随着时间的推移.
  • 为了研究患有阿尔茨海默病和没有阿尔茨海默病的个体之间肝脏Aβ沉积的差异.
  • 为肝脏Aβ检测建立最佳的成像窗口.

主要方法:

  • 在全身uEXPLORER PET系统上进行了F-florbetaben动态PET成像.
  • 感兴趣的区域被定义为八个肝脏部分和一个复合肝脏区域.
  • 标准化摄入值比率 (SUVR) 时间活动曲线使用线性混合效应模型进行了分析.

主要成果:

  • 患有AD的个体 (Aβ+) 与对照组 (Aβ-) 相比,在较晚的时间点 (90-110分钟) 显示肝脏SUVR显著增加.
  • 在以后的时间点,Aβ+和Aβ-组之间的歧视最为显著.
  • 早期和中期时间点在肝脏SUVR.中显示出有限的歧视.

结论:

  • 肝脏表现出一种随时间变化的粉样蛋白信号,类似于大脑.
  • 90-110分钟的时间窗口是使用PET评估肝脏粉样蛋白负担的最佳时间窗口.
  • 这些发现支持肝脏作为AD和全身分子过程的潜在外围生物标志物.